Asia Pacific Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Country: Trend Forecast and Growth Opportunity

November 2023 | 131 pages | ID: AD0AB6D0D946EN
GMD Research

Abstracts

Asia Pacific small molecule API market will grow by 8.7% annually with a total addressable market cap of over $1 trillion over 2023-2032, driven by the increasing incidences of diseases, the development of high-potency small molecule APIs, patents expiry of the top-selling pharmaceuticals, the increasing technological developments in manufacturing sector, and a surging healthcare expenditure.

Highlighted with 67 tables and 51 figures, this 131-page report “Asia Pacific Small Molecule API Market 2022-2032 by Source (Synthetic, Semi-synthetic, Natural), Product Type (Standard, HPAPI), Therapeutic Area, Application (Clinical, Commercial), Manufacturer Type (Pharma, CMO), and Country: Trend Forecast and Growth Opportunity” is based on comprehensive research of the entire Asia Pacific small molecule API market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2020-2022 and provides forecast from 2023 till 2032 with 2022 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces

The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific small molecule API market in every aspect of the classification from perspectives of Source, Product Type, Therapeutic Area, Application, Manufacturer Type, and Country.

Based on Source, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Synthetic API
• Branded Synthetic API
• Generic Synthetic API
• Semi-synthetic API
• Natural Origin

Based on Product Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Standard API
• High Potency API (HPAPI)
• Branded HPAPI
• Generic HPAPI

By Therapeutic Area, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Infectious Diseases
• Oncology
• Ophthalmology
• Cardiovascular Disorders
• Central Nervous System
• Respiratory Disorders
• Metabolic Diseases
• Other Therapeutic Areas

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Clinical Use
• Commercial Use

By Manufacturer Type, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2022-2032 included in each section.

• Pharmaceutical Companies
• CMOs

Geographically, the following national/local markets are fully investigated:

• Japan
• China
• South Korea
• Australia
• India
• Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)

For each key country, detailed analysis and annual revenue ($ mn) are available for 2022-2032. The breakdown of national markets by Product Type, Therapeutic Area, and Manufacturer Type over the forecast years are also included.

The report also covers the current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

Aurobindo Pharma Ltd.

Cambrex Corporation

Catalent Inc.

Dr. Reddy's Laboratories

GlaxoSmithKline plc

Lonza Group

Merck & Co., Inc.

Mylan N.V.

Novartis AG

Pfizer Inc.

Sun Pharmaceutical Industries Ltd.

Teva Pharmaceutical Industries Ltd.

Wuxi AppTec Co., Ltd.

(Please note: The report will be updated before delivery so that the latest historical year is the base year, and the forecast covers at least 5 years over the base year.)

Contents

1 INTRODUCTION

1.1 Industry Definition and Research Scope
  1.1.1 Industry Definition
  1.1.2 Research Scope
1.2 Research Methodology
  1.2.1 Overview of Market Research Methodology
  1.2.2 Market Assumption
  1.2.3 Secondary Data
  1.2.4 Primary Data
  1.2.5 Data Filtration and Model Design
  1.2.6 Market Size/Share Estimation
  1.2.7 Research Limitations
1.3 Executive Summary

2 MARKET OVERVIEW AND DYNAMICS

2.1 Market Size and Forecast
  2.1.1 Impact of COVID-19 on World Economy
  2.1.2 Impact of COVID-19 on the Market
  2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis

3 SEGMENTATION OF ASIA PACIFIC MARKET BY SOURCE

3.1 Market Overview by Source
3.2 Synthetic API
  3.2.1 Branded Synthetic API
  3.2.2 Generic Synthetic API
3.3 Semi-synthetic API
3.4 Natural Origin

4 SEGMENTATION OF ASIA PACIFIC MARKET BY PRODUCT TYPE

4.1 Market Overview by Product Type
4.2 Standard API
4.3 High Potency API (HPAPI)
  4.3.1 Branded HPAPI
  4.3.2 Generic HPAPI

5 SEGMENTATION OF ASIA PACIFIC MARKET BY THERAPEUTIC AREA

5.1 Market Overview by Therapeutic Area
5.2 Infectious Diseases
5.3 Oncology
5.4 Ophthalmology
5.5 Cardiovascular Disorders
5.6 Central Nervous System
5.7 Respiratory Disorders
5.8 Metabolic Diseases
5.9 Other Therapeutic Areas

6 SEGMENTATION OF ASIA PACIFIC MARKET BY APPLICATION

6.1 Market Overview by Application
6.2 Clinical Use
6.3 Commercial Use

7 SEGMENTATION OF ASIA PACIFIC MARKET BY MANUFACTURER TYPE

7.1 Market Overview by Manufacturer Type
7.2 Pharmaceutical Companies
7.3 CMOs

8 ASIA-PACIFIC MARKET 2022-2032 BY COUNTRY

8.1 Overview of Asia-Pacific Market
8.2 Japan
8.3 China
8.4 Australia
8.5 India
8.6 South Korea
8.7 Rest of APAC Region

9 COMPETITIVE LANDSCAPE

9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
Aurobindo Pharma Ltd.
Cambrex Corporation
Catalent Inc.
Dr. Reddy's Laboratories
GlaxoSmithKline plc
Lonza Group
Merck & Co., Inc.
Mylan N.V.
Novartis AG
Pfizer Inc.
Sun Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd.
Wuxi AppTec Co., Ltd.
RELATED REPORTS

List Of Tables

LIST OF TABLES

Table 1. Snapshot of Asia Pacific Small Molecule API Market in Balanced Perspective, 2022-2032
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. Scenarios for Economic Impact of Ukraine Crisis
Table 5. World Health Spending by Region, $ bn, 2013-2020
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn
Table 7. Main Product Trends and Market Opportunities in Asia Pacific Small Molecule API Market
Table 8. Asia Pacific Small Molecule API Market by Source, 2022-2032, $ mn
Table 9. Asia Pacific Small Molecule API Market: Synthetic API by Drug Type, 2022-2032, $ mn
Table 10. Asia Pacific Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 11. Asia Pacific Small Molecule API Market: HPAPI by Drug Type, 2022-2032, $ mn
Table 12. Asia Pacific Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 13. Asia Pacific Small Molecule API Market by Application, 2022-2032, $ mn
Table 14. Asia Pacific Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 15. APAC Small Molecule API Market by Country, 2022-2032, $ mn
Table 16. Japan Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 17. Japan Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 18. Japan Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 19. China Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 20. China Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 21. China Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 22. Australia Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 23. Australia Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 24. Australia Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 25. India Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 26. India Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 27. India Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 28. South Korea Small Molecule API Market by Product Type, 2022-2032, $ mn
Table 29. South Korea Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn
Table 30. South Korea Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn
Table 31. Small Molecule API Market in Rest of APAC by Country/Region, 2022-2032, $ mn
Table 32. Aurobindo Pharma Ltd.: Company Snapshot
Table 33. Aurobindo Pharma Ltd.: Business Segmentation
Table 34. Aurobindo Pharma Ltd.: Product Portfolio
Table 35. Cambrex Corporation: Company Snapshot
Table 36. Catalent Inc.: Company Snapshot
Table 37. Catalent Inc.: Business Segmentation in 2018
Table 38. Catalent Inc.: Product Portfolio
Table 39. Catalent Inc.: Revenue, 2018-2020, $ million
Table 40. Catalent Inc.: Revenue by Region in 2018
Table 41. Dr. Reddy's Laboratories: Company Snapshot
Table 42. Dr. Reddy's Laboratories: Business Segmentation
Table 43. Dr. Reddy's Laboratories: Revenue, 2018-2020, $ bn
Table 44. GlaxoSmithKline: Company Snapshot
Table 45. GlaxoSmithKline: Business Segmentation
Table 46. GlaxoSmithKline: Product Portfolio
Table 47. GlaxoSmithKline: Revenue, 2018-2020, $ bn
Table 48. Lonza Group: Company Snapshot
Table 49. Lonza Group: Business Segmentation in 2018
Table 50. Lonza Group: Product Portfolio
Table 51. Lonza Group: Revenue by Region in 2018
Table 52. Merck & Co., Inc.: Company Snapshot
Table 53. Merck & Co., Inc.: Business Segmentation
Table 54. Merck & Co., Inc.: Revenue, 2018-2020, $ bn
Table 55. Mylan NV: Company Snapshot
Table 56. Mylan NV: Revenue, 2017-2019, $ bn
Table 57. Novartis International AG: Company Snapshot
Table 58. Novartis International AG: Business Segmentation
Table 59. Novartis International AG: Revenue, 2017-2019, $ bn
Table 60. Pfizer Inc.: Company Snapshot
Table 61. Pfizer Inc.: Business Segmentation
Table 62. Pfizer Inc.: Product Portfolio
Table 63. Pfizer Inc.: Revenue, 2018-2020, $ bn
Table 64. Sun Pharmaceutical Industries Limited: Company Snapshot
Table 65. Teva Pharmaceutical Industries Ltd.: Company Snapshot
Table 66. Teva Pharmaceutical Industries Ltd.: Business Segmentation
Table 67. WuXi AppTec Inc.: Company Snapshot

List Of Figures

LIST OF FIGURES

Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032
Figure 4. Asia Pacific Small Molecule API Market, 2022-2032, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific Small Molecule API Market
Figure 7. Primary Restraints and Impact Factors of Asia Pacific Small Molecule API Market
Figure 8. Investment Opportunity Analysis
Figure 9. Porter’s Fiver Forces Analysis of Asia Pacific Small Molecule API Market
Figure 10. Breakdown of Asia Pacific Small Molecule API Market by Source, 2022-2032, % of Revenue
Figure 11. Asia Pacific Addressable Market Cap in 2023-2032 by Source, Value ($ mn) and Share (%)
Figure 12. Asia Pacific Small Molecule API Market by Source: Synthetic API, 2022-2032, $ mn
Figure 13. Asia Pacific Small Molecule API Market by Synthetic API: Branded Synthetic API, 2022-2032, $ mn
Figure 14. Asia Pacific Small Molecule API Market by Synthetic API: Generic Synthetic API, 2022-2032, $ mn
Figure 15. Asia Pacific Small Molecule API Market by Source: Semi-synthetic API, 2022-2032, $ mn
Figure 16. Asia Pacific Small Molecule API Market by Source: Natural Origin, 2022-2032, $ mn
Figure 17. Breakdown of Asia Pacific Small Molecule API Market by Product Type, 2022-2032, % of Sales Revenue
Figure 18. Asia Pacific Addressable Market Cap in 2023-2032 by Product Type, Value ($ mn) and Share (%)
Figure 19. Asia Pacific Small Molecule API Market by Product Type: Standard API, 2022-2032, $ mn
Figure 20. Asia Pacific Small Molecule API Market by Product Type: High Potency API (HPAPI), 2022-2032, $ mn
Figure 21. Asia Pacific Small Molecule API Market by HPAPI: Branded HPAPI, 2022-2032, $ mn
Figure 22. Asia Pacific Small Molecule API Market by HPAPI: Generic HPAPI, 2022-2032, $ mn
Figure 23. Breakdown of Asia Pacific Small Molecule API Market by Therapeutic Area, 2022-2032, % of Sales Revenue
Figure 24. Asia Pacific Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%)
Figure 25. Asia Pacific Small Molecule API Market by Therapeutic Area: Infectious Diseases, 2022-2032, $ mn
Figure 26. Asia Pacific Small Molecule API Market by Therapeutic Area: Oncology, 2022-2032, $ mn
Figure 27. Asia Pacific Small Molecule API Market by Therapeutic Area: Ophthalmology, 2022-2032, $ mn
Figure 28. Asia Pacific Small Molecule API Market by Therapeutic Area: Cardiovascular Disorders, 2022-2032, $ mn
Figure 29. Asia Pacific Small Molecule API Market by Therapeutic Area: Central Nervous System, 2022-2032, $ mn
Figure 30. Asia Pacific Small Molecule API Market by Therapeutic Area: Respiratory Disorders, 2022-2032, $ mn
Figure 31. Asia Pacific Small Molecule API Market by Therapeutic Area: Metabolic Diseases, 2022-2032, $ mn
Figure 32. Asia Pacific Small Molecule API Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn
Figure 33. Breakdown of Asia Pacific Small Molecule API Market by Application, 2022-2032, % of Revenue
Figure 34. Asia Pacific Addressable Market Cap in 2023-2032 by Application, Value ($ mn) and Share (%)
Figure 35. Asia Pacific Small Molecule API Market by Application: Clinical Use, 2022-2032, $ mn
Figure 36. Asia Pacific Small Molecule API Market by Application: Commercial Use, 2022-2032, $ mn
Figure 37. Breakdown of Asia Pacific Small Molecule API Market by Manufacturer Type, 2022-2032, % of Revenue
Figure 38. Asia Pacific Addressable Market Cap in 2023-2032 by Manufacturer Type, Value ($ mn) and Share (%)
Figure 39. Asia Pacific Small Molecule API Market by Manufacturer Type: Pharmaceutical Companies, 2022-2032, $ mn
Figure 40. Breakdown of Asia Pacific Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue
Figure 41. Asia Pacific Small Molecule API Market by Manufacturer Type: CMOs, 2022-2032, $ mn
Figure 42. Breakdown of Asia Pacific Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue
Figure 43. Breakdown of APAC Small Molecule API Market by Country, 2022 and 2032, % of Revenue
Figure 44. Contribution to APAC 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 45. Small Molecule API Market in Japan, 2022-2032, $ mn
Figure 46. Small Molecule API Market in China, 2022-2032, $ mn
Figure 47. Small Molecule API Market in Australia, 2022-2032, $ mn
Figure 48. Small Molecule API Market in India, 2022-2032, $ mn
Figure 49. Small Molecule API Market in South Korea, 2022-2032, $ mn
Figure 50. Small Molecule API Market in Rest of APAC, 2022-2032, $ mn
Figure 51. Growth Stage of Asia Pacific Small Molecule API Industry over the Forecast Period